daigen bpc-157 BPC-157 Peptide – High Purity
Description
The amount of medication to be drawn into the syringe will be determined by your healthcare provider
No lethal dose identified at doses up to 20 mg/kg in animal studies No organ toxicity observed across multiple organ systems Negative mutagenicity testing across standard assays No teratogenic effects in pregnancy studies Limited long-term human data beyond 6 weeks Theoretical Considerations The primary theoretical concern relates to BPC-157s angiogenic properties
In fact, actual results may differ materially
Lyophilization removes water, which slows many degradation pathways and makes the material easier to ship and store
Bob Scottland Retired R.N.
Patients may read about thymosin beta-4 wound-healing studies and assume the same conclusions apply directly to commercially marketed TB-500 products
